Report : A-Z CDF items in Formulary 27/02/2021 10:20:29
[
Back
]
Section
Status
Homecare
Name
13.05.03
Restricted Use
Adalimumab Amgevita
®
,Humira
®
, Imraldi
®
13.05.03
Restricted Use
Apremilast Otezla
®
03.04.02
Restricted Use
Benralizumab Fasenra
®
06.06.02
Non Formulary
Burosumab Crysvita®
13.05.01
Restricted Use
Dupilumab Dupixent
®
02.11
Restricted Use
Emicizumab Hemlibra®
13.05.03
Restricted Use
Etanercept Enbrel
®
, Benepali
®
03.07
Restricted Use
Ivacaftor
03.04.03
Restricted Use
Lanadelumab Takhzyro
®
03.07
Restricted Use
Lumacaftor/ivacaftor Orkambi®
10.02
Restricted Use
Nusinersen Spinraza
®
10.02
Restricted Use
Risdiplam Evrysdi
13.05.03
Restricted Use
Secukinumab Cosentyx
®
03.07
Restricted Use
Tezacaftor/Ivacaftor Symkevi®
13.05.03
Restricted Use
Ustekinumab
Cambridgeshire and Peterborough